Reply to: Comment on "iMTSS: an integrated framework for biology- and patient-driven prognosis in myelofibrosis undergoing transplantation".

Gagelmann N, Kröger N

Open source

DOI
10.1016/j.jtct.2026.09.040
Published
2026 Sep 24
Container
Transplantation and cellular therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jtct.2026.09.040,
  title = {Reply to: Comment on "iMTSS: an integrated framework for biology- and patient-driven prognosis in myelofibrosis undergoing transplantation".},
  author = {Gagelmann N and Kröger N},
  year = {2026},
  journal = {Transplantation and cellular therapy},
  doi = {10.1016/j.jtct.2026.09.040},
  url = {https://doi.org/10.1016/j.jtct.2026.09.040}
}

RIS

TY  - JOUR
TI  - Reply to: Comment on "iMTSS: an integrated framework for biology- and patient-driven prognosis in myelofibrosis undergoing transplantation".
AU  - Gagelmann N
AU  - Kröger N
PY  - 2026
JO  - Transplantation and cellular therapy
DO  - 10.1016/j.jtct.2026.09.040
UR  - https://doi.org/10.1016/j.jtct.2026.09.040
ER  - 

APA

N, G., & N, K. (2026). Reply to: Comment on "iMTSS: an integrated framework for biology- and patient-driven prognosis in myelofibrosis undergoing transplantation".. Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2026.09.040

Source records